The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Open accessAbstract
Iron is essential for many biological processes, including oxygen delivery, and its supply is tightly regulated. Hepcidin, a small peptide synthesized in the liver, is a key regulator of iron absorption and homeostasis in mammals. Hepcidin production is increased by iron overload and decreased by anemia and hypoxia; but the molecular mechanisms that govern the hepcidin response to these stimuli are not known. Here we establish that the von Hippel-Lindau/hypoxia-inducible transcription factor (VHL/HIF) pathway is an essential link between iron homeostasis and hepcidin regulation in vivo. Through coordinate downregulation of hepcidin and upregulation of erythropoietin and ferroportin, the VHL-HIF pathway mobilizes iron to support erythrocyte production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, HIF effects (via hepcidin) the mobilisation or iron and can cause the expression of inflammatory cytokines such as IL-1, IL-6 and TNF-α [2254-2256] under conditions (hypoxia) where superoxide and peroxide production are likely to be increased, and consequently increases sepsis (in that HIF-knockout mice are resistant to LPS-induced sepsis [2254,2255]).”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2254]
In the citing paper
“and several proteins induced by hypoxia such as hypoxia inducible factor-1 (HIF-1) or platelet derived growth factor BB (PDGF-BB) reduce hepcidin expression, thereby enhancing iron delivery for erythropoiesis (Peyssonnaux et al., 2007; Sonnweber et al., 2014).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Peyssonnaux et al., 2007
In the citing paper
“The von Hippel-Lindau/hypoxia-inducible transcription factor (HIF) system also appears to control hepcidin expression, with HIF1␣ acting as a repressor when it binds to the hepcidin promoter.109”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [109]
In the citing paper
“Experimental studies in cultured cells, in animal models and in human subjects have established that hepcidin production is O2-sensitive and involves the HIF pathway.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [193]
In the citing paper
“Subsequent investigation revealed that Nrf2 and AP1 family transcription factors, in conjunction with transcriptional coactivator p300/CBP, are involved in the activation of the ARE (246, 302, 306, 307)”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [246]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 1×
“As Albumin-Cre/VHLflox/flox mice exhibit hepatic inflammation and steatosis (21) (Figure 2C), we examined levels of the proinflammatory cytokine IL-6, which is known to stimulate hepcidin expression and may contribute to the anemia of chronic inflammation (5).”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J. S., Hanif, A., Bajantri, B., & Chilimuri, S. S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,353
Tian, H., McKnight, S. L., & Russell, D. W. (1997) · Genes & Development · doi:10.1101/gad.11.1.72 · Cited by 1,351
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,301
A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Self-citationNicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Self-citation
Flagged first, then by citations
Research works printed but not linked: 4
- Gu, 1998, Gene Expr., 7, 205
- Wenger, 1997, Biol. Chem., 378, 609
- Mazure, 2002, Cancer Res., 62, 1158
- Brugnara, 1994, J. Lab. Clin. Med., 123, 660
Cited by
Sorted by citations
Items 401–500 of 637
Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin.
Krijt, J., Fujikura, Y., Šefc, L., Vokurka, M., Hlobenová, T., & Necas, E. (2010) · PubMed · doi:10.33549/physiolres.931706 · Cited by 16
Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients
Javaheri-Kermani, M., Farazmandfar, T., Ajami, A., & Yazdani, Y. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.929736 · Cited by 15
Yan, P., Li, N., Ma, M., Liu, Z., Yang, H., Li, J., Wan, C., Gao, S., Li, S., Zheng, L. T., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01578-2 · Cited by 15
Yadav, P. K., Singh, S., & Singh, A. K. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107557 · Cited by 15
Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?
Bond, P., Verdegaal, T. J., & Smit, D. L. (2024) · Endocrine Connections · doi:10.1530/ec-24-0283 · Cited by 19
Suppression of plasma hepcidin by venesection during steady-state hypoxia
Talbot, N. P., Smith, T. G., Lakhal‐Littleton, S., Gülsever, C. İ., Rivera, M. C., Dorrington, K. L., Mole, D. R., & Robbins, P. A. (2016) · Blood · doi:10.1182/blood-2015-05-647404 · Cited by 15
Mehanna, E. T., Ali, A.-S. A., El-shaarawy, F. F., Mesbah, N. M., Abo–Elmatty, D. M., & Aborehab, N. M. (2021) · Molecules · doi:10.3390/molecules26247437 · Cited by 15
Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.
Park, S., & Chan, C. (2012) · PubMed · doi:10.14670/hh-27.975 · Cited by 14
Newman, M., Nik, S. H. M., Sutherland, G. T., Hin, N., Kim, W. S., Halliday, G. M., Jayadev, S., Smith, C., Laird, A. S., Lucas, C. W., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa119 · Cited by 15
Kristan, A., Debeljak, N., & Kunej, T. (2019) · European Journal Of Haematology · doi:10.1111/ejh.13304 · Cited by 14
Activation of Intestinal HIF2α Ameliorates Iron‐Refractory Anemia
Yu, Y., Su, Y., Yang, S., Liu, Y., Lin, Z., Das, N. K., Wu, Q., Zhou, J., Sun, S., Li, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202307022 · Cited by 14
Tan, S.-J., Satake, S., Smith, E. R., Toussaint, N. D., Hewitson, T. D., & Holt, S. G. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.217 · Cited by 14
Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer
Shibabaw, T., Teferi, B., Molla, M. D., & Ayelign, B. (2020) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s276404 · Cited by 15
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis
Zhang, L., Hou, J., Li, J., Su, S., & Xue, S. (2021) · Aging · doi:10.18632/aging.203143 · Cited by 14
McElroy, A. E., Hice, L. A., Frisk, M. G., Purcell, S. L., Phillips, N. C., & Fast, M. D. (2015) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2015.01.006 · Cited by 14
Sánchez‐González, C., Rivas‐García, L., López-Chaves, C., Rodríguez‐Nogales, A., Algieri, F., Gálvez, J., Gómez-Aracena, J., Ramírez, L. V., Montes‐Bayón, M., Sanz‐Medel, A., et al. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.08.011 · Cited by 14
Higashijima, Y., Tanaka, T., & Nangaku, M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.796358 · Cited by 14
Regulation of transferrin receptor 2 in human cancer cell lines
Calzolari, A., Finisguerra, V., Oliviero, I., Deaglio, S., Mariani, G., Malavasi, F., & Testa, U. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.10.001 · Cited by 13
Identification of differentially expressed genes in mouse embryonic stem cell under hypoxia
Hwang, S. J., & Lee, H. (2020) · Genes & Genomics · doi:10.1007/s13258-020-01009-4 · Cited by 13
Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease
Ginzburg, Y. Z. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.03.001 · Cited by 15
Elliott, J. (2023) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.13127 · Cited by 15
Han, M., Böhlke, M., Maher, T. J., & Kim, J. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03166-1 · Cited by 13
Kuo, C., Hsieh, P., Chiu, V. J.-Y., Lan, C., & Lu, K. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/7736638 · Cited by 15
Xu, C., Dong, C., Xu, C., Han, T., Bao, S., & Gao, X. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-0166-6 · Cited by 13
PKC-δ inhibitors sustain self-renewal of mouse embryonic stem cells under hypoxiain vitro
Lee, H., Jeong, C., Cha, J., & Kim, K.-W. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.4.028 · Cited by 13
Emerging drugs for the treatment of kidney disease-induced anemia
Małyszko, J., & Małyszko, J. S. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1220537 · Cited by 14
Bignucolo, A., Lemire, J. A., Auger, C., Castonguay, Z., Appanna, V. P., & Vasu, D. (2012) · InTech eBooks · doi:10.5772/30273 · Cited by 13
Urinary hepcidin excretion in patients with low grade myelodysplastic syndrome
Murphy, P. T., Mitra, S., Gleeson, M. J., Desmond, R. G., & Swinkels, D. W. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07455.x · Cited by 13
Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease
McMahon, G. M., & Singh, A. K. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000554 · Cited by 12
Bajbouj, K., Shafarin, J., Muhammad, J. S., Ali, A., Unnikannan, H., Suleiman, B., Al-Jabi, N., Menon, K., & Hamad, M. A. (2020) · Immunobiology · doi:10.1016/j.imbio.2020.151995 · Cited by 12
Hognon, C., Bignon, E., Harlé, G., Touche, N., Grandemange, S., & Monari, A. (2021) · Biomolecules · doi:10.3390/biom11091329 · Cited by 14
Quantitative assay of urinary hepcidin using MALDI-TOF mass spectrometry
Gay, M. C. L., Mullaney, I., Trinder, D., Olynyk, J. K., & Trengove, R. D. (2009) · Analytical Methods · doi:10.1039/b9ay00130a · Cited by 12
Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell lines
Khurana, A., Tun, H. W., Marlow, L. A., Copland, J. A., Dredge, K. S., & Shridhar, V. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20824 · Cited by 15
Aral, A., Ergün, M. A., Engin, A. B., Börcek, A. Ö., & Bolay, H. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2003-41 · Cited by 12
Hypoxia-inducible factor signaling in vascular calcification in chronic kidney disease patients
Çöpür, S., Uçku, D., Cozzolino, M. G., & Kanbay, M. (2022) · Journal of Nephrology · doi:10.1007/s40620-022-01432-8 · Cited by 14
Molecular basis of hereditary iron homeostasis defects
Horváthová, M., Ponka, P., & Divoký, V. (2010) · Hematology · doi:10.1179/102453310x12583347009810 · Cited by 12
Fibroblast Growth Factor 23 Bone Regulation and Downstream Hormonal Activity
Clinkenbeard, E. L. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01092-1 · Cited by 12
Physiological focus on the erythropoietin–hepcidin–ferroportin axis
D’Anna, M. C., & Roque, M. E. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0214 · Cited by 11
Tallec-Estève, N. L., Rousseau, C., Desrues, B., Loréal, O., & Thibault, R. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.06.007 · Cited by 10
Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension
Hopkins, C. D., Wessel, C. R., Chen, O., El‐Kersh, K., Cave, M. C., Cai, L. F., & Huang, J. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85590 · Cited by 11
A Novel Muscle Atrophy Mechanism: Myocyte Degeneration Due to Intracellular Iron Deprivation
Suh, D. K., Lee, W.-Y., Yeo, W. J., Kyung, B. S., Jung, K. W., Seo, H. K., Lee, Y.-S., & Suh, D. W. (2022) · Cells · doi:10.3390/cells11182853 · Cited by 12
Hepcidin and iron metabolism disorders in patients with chronic kidney disease
Jelic, M., Cvetković, T., Djordjevic, V., Damnjanović, G., Vlahović, P., Kocic, G. M., Djindjić, N., Jovović, B., & Antic, A. (2013) · Vojnosanitetski pregled · doi:10.2298/vsp1304368j · Cited by 10
Manalo, D. J., Baek, J. H., Buehler, P. W., Struble, E. B., Abraham, B., & Alayash, A. I. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.085 · Cited by 10
Chen, T., Rotival, M., Chiu, L.-Y., Bagnati, M., Ko, J., Srivastava, P. K., Petretto, E. G., Pusey, C. D., Lai, P., Aitman, T. J., et al. (2017) · Genetics · doi:10.1534/genetics.116.197376 · Cited by 10
Dimitriadis, A., Foka, P., Kyratzopoulou, E., Karamichali, E., Petroulia, S., Tsitoura, P., Kakkanas, A., Eliadis, P., Georgopoulou, U., & Mamalaki, A. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.13048 · Cited by 10
Expression of Iron Regulatory Protein 1 Is Regulated not only by HIF-1 but also pCREB under Hypoxia
Luo, Q., Qian, Z., Zhou, Y., Zhang, M., Wang, D., Zhu, L., & Ke, Y. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.16437 · Cited by 10
Hypoxia and HIF-1α promote lytic de novo KSHV infection
Lee, S.-C., Naik, N. G., Tombácz, D., Gulyás, G. M., Kakuk, B., Boldogkői, Z., Hall, K., Papp, B., Boulant, S., & Tóth, Z. (2023) · Journal of Virology · doi:10.1128/jvi.00972-23 · Cited by 10
Liu, J., Zhao, J., He, J., Li, Y., Xu, J., Xiao, C., Zhang, Y., Chen, H., Hu, Y., Fan, C., et al. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02079-z · Cited by 9
Zhou, Q., Mao, M., Li, J., & Deng, F. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2195011 · Cited by 12
WU, J., Liao, Q., ZHANG, L., WU, S., & LIU, Z. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.031404 · Cited by 10
The effect of hemin‐induced oxidative stress on erythropoietin production in HepG2 cells
Nishimura, K., Tokida, M., Katsuyama, H., Nakagawa, H., & Matsuo, S. (2014) · Cell Biology International · doi:10.1002/cbin.10329 · Cited by 9
Hamad, M. A., & Awadallah, S. M. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.10.019 · Cited by 9
An immunoassay for human serum hepcidin at last: Ganz klar?
Brugnara, C. (2008) · Blood · doi:10.1182/blood-2008-09-176701 · Cited by 9
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
van Genugten, E. A. J., Weijers, J. A. M., Heskamp, S., Kneilling, M., van den Heuvel, M. M., Piet, B., Bussink, J., Hendriks, L. E. L., & Aarntzen, E. H. J. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.786089 · Cited by 9
Dietary Iron Absorption: Biochemical and Nutritional Aspects
Frazer, D. M., Anderson, G. J., & Collins, J. F. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_6 · Cited by 8
Iron, the Essential Micronutrient: A Comprehensive Review of Regulatory Pathways of Iron Metabolism
Horváth, A., Tamási, K., Pap, R., Jánosa, G., & Pandur, E. (2025) · Nutrients · doi:10.3390/nu18010109 · Cited by 12
Tanaka, H., Li, Z., Ikuta, K., Addo, L., Akutsu, H., Nakamura, M., Sasaki, K., Ohtake, T., Fujiya, M., Torimoto, Y., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02192.x · Cited by 8
The Re-Emerging Role of Iron in Infection and Immunity
Hamad, M. A., & Bajbouj, K. (2016) · Integrative Molecular Medicine · doi:10.15761/imm.1000251 · Cited by 8
HIF1A: A Putative Modifier of Hemochromatosis
Pelucchi, S., Ravasi, G., Arosio, C., Mauri, M., Piazza, R., Mariani, R., & Piperno, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031245 · Cited by 8
Masoumi, Z. T., Hansson, L. R., Hansson, E., Ahlm, E., Mezey, É., Erlandsson, L., & Hansson, S. R. (2023) · Placenta · doi:10.1016/j.placenta.2023.01.008 · Cited by 8
Iron Metabolism and Related Disorders
Hoda, K., Bowlus, C. L., Chu, T. W., & Gruen, J. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00106-3 · Cited by 8
Serum hepcidin assay in 2011: where do we stand?
Delaby, C., & Beaumont, C. (2012) · Annales de biologie clinique · doi:10.1684/abc.2012.0725 · Cited by 8
Ribeiro, S., Garrido, P., Fernandes, J. C., Rocha‐Pereira, P., Costa, E. M., Belo, L., Reis, F., & Santos‐Silva, A. (2016) · BioFactors · doi:10.1002/biof.1275 · Cited by 8
Paterson, A. C., & Pietrangelo, A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00005-2 · Cited by 9
Shafarin, J., Bajbouj, K., El-Serafi, A. T., Sandeep, D., & Hamad, M. A. (2016) · Biology and Medicine · doi:10.4172/0974-8369.1000356 · Cited by 8
Regulation of Iron Absorption and Distribution
Latunde-Dada, G. O., & Simpson, R. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_2 · Cited by 8
Iron metabolism in macrophages from HFE hemochromatosis patients
Jacolot, S., Yang, Y., Paitry, P., Férec, C., & Mura, C. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.07.010 · Cited by 8
The Role of Estrogen Signaling in Cellular Iron Metabolism in Pancreatic β Cells
Taneera, J., Ali, A., & Hamad, M. A. (2022) · Pancreas · doi:10.1097/mpa.0000000000001978 · Cited by 7
Research Translation and Personalized Medicine
Brugarolas, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_8 · Cited by 7
AMP‐activated protein kinase α1 phosphorylates PHD2 to maintain systemic iron homeostasis
Wang, C., Zhang, W., Xu, W., Liu, Z., & Huang, K. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.854 · Cited by 9
Wu, M., Zang, C., Ma, F., Chen, B., Liu, J., & Xu, Z. (2022) · Clinical and Experimental Nephrology · doi:10.1007/s10157-022-02263-4 · Cited by 7
Lelièvre, E., Bureau, C., Bordat, Y., Frétaud, M., Langevin, C., Jopling, C., & Kissa, K. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049488 · Cited by 7
Bartnikas, T. B., Fleming, M. D., & Schmidt, P. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.011 · Cited by 7
Hegde, N. V., Unger, E. L., Jensen, G. L., Hankey, P. A., & Paulson, R. F. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00463.2010 · Cited by 7
Hypobaric hypoxia-mediated protein expression in plasma of susceptible & tolerant rats.
Kumar, S., Sharma, P., Bansal, A., Sharma, P. C., & Aggarwal, K. K. (2014) · Europe PMC (PubMed Central) · Cited by 7
Cellular and Molecular Defenses Against Hypoxia
Frede, S., & Fandrey, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8772-2_2 · Cited by 8
Devi, L., Sasan, S., Changotra, A., & Kapoor, K. K. (2024) · New Journal of Chemistry · doi:10.1039/d4nj01359j · Cited by 6
Song, J., Xu, S., Chen, Q., Gou, Y., Zhao, C., Jia, C., Liu, H., Zhang, Z., Li, B., Gao, Y., et al. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18543 · Cited by 5
Toxicity of the iron siderophore mycobactin J in mouse macrophages: Evidence for a hypoxia response
McQueen, C. F., & Groves, J. T. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111669 · Cited by 6
Hamidi, A., Wolf, A., Dueva, R., Kaufmann, M., Göpelt, K., Iliakis, G. E., & Metzen, E. (2022) · Cells · doi:10.3390/cells11101671 · Cited by 6
New Players in Neuronal Iron Homeostasis: Insights from CRISPRi Studies
Bórquez, D. A., Castro, F. B. D., Núñez, M. T., & Urrutia, P. J. (2022) · Antioxidants · doi:10.3390/antiox11091807 · Cited by 6
Idiopathic erythrocytosis: a germline disease?
Elli, E. M., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., Pelucchi, S., Spinelli, S., Manghisi, B., Cavalca, F., et al. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01283-y · Cited by 6
Yeruva, S. L. H., Nwabudike, S. M., Ogbonna, O. H., & Oneal, P. A. (2015) · Case Reports in Hematology · doi:10.1155/2015/784783 · Cited by 6
Les facteurs de transcription HIF : régulateurs clés du métabolisme du fer ?
Peyssonnaux, C. (2008) · médecine/sciences · doi:10.1051/medsci/2008242137 · Cited by 7
Self-citationKong, W., Cui, Y., Fu, Y., Lei, Y., Ci, Y., Bao, Y., Zhao, S., Xie, L., Chang, Y., & Zhao, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26715 · Cited by 6
Role of iron overload and ferroptosis in heart disease
Cai, Z., Min, J., Wang, H., Fang, X., & Wang, F. (2019) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2019-0242 · Cited by 6
Tamaki, M., Inagaki, T., Minato, M., Shibata, E., Nishioka, R., Nishioka, S., Matsubara, Y., Sasaki, M., Tamaki, M., Tamaki, M., et al. (2024) · Internal Medicine · doi:10.2169/internalmedicine.3773-24 · Cited by 5
A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis
Giordano, A., Stridh, P., Preziosa, P., Pisa, M., Lerma-Martin, C., Sorosina, M., Mascia, E., Santoro, S., Misra, K., Clarelli, F., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02984-w · Cited by 7
Kondo, S., Ferdousi, F., Yamauchi, K., Suidasari, S., Yokozawa, M., Harrabi, M. M., Tominaga, K., & Isoda, H. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16752 · Cited by 5
Diseased red blood cells topple iron balance
Chou, S. T., & Weiss, M. J. (2007) · Nature Medicine · doi:10.1038/nm0907-1020 · Cited by 5
Laboratory use of hepcidin in renal transplant recipients
Šimetić, L., & Zibar, L. (2016) · Biochemia Medica · doi:10.11613/bm.2016.003 · Cited by 5
Genetics of Adaptation to High Altitude
Labie, D., & Élion, J. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0023850 · Cited by 5
TheHIF2AGene in Familial Erythrocytosis
Eltzschig, H. K., Kasmi, K. C. E., & Eckle, T. D. L. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmc080274 · Cited by 5
Liu, X., Yan, T., Xu, Y., Zheng, X., & Wu, D. (2025) · Drug Testing and Analysis · doi:10.1002/dta.3870 · Cited by 4
The effects of intracellular iron availability on the outcome of Toxoplasma gondii infection in mice
Mostafa, E., Ahmed, F. A.-S. M. S., Yahia, S. H., Ibrahim, A. I. M., & Elbahaie, E. S. (2023) · Journal of Parasitic Diseases · doi:10.1007/s12639-023-01603-9 · Cited by 4
Mokhtarifar, A., Zeydabadi, F. A., Asili, J., Kooshyar, M. M., & Sahebkar, A. (2016) · Comparative Clinical Pathology · doi:10.1007/s00580-016-2335-9 · Cited by 4
Patel, H., Soni, K., Trivedi, R., Heading, H., Geue, J., Kansagra, K., Gupta, R. J., Pandya, V. B., Srinivas, N. R., Patel, P., et al. (2017) · Bioanalysis · doi:10.4155/bio-2017-0014 · Cited by 4
Pietrangelo, A., & Torbenson, M. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00004-2 · Cited by 4
Torbett, B. E., & Friedman, J. S. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8698-6_1 · Cited by 5
GDF15 coupable de l’hypersidérémie des patients thalassémiques par extinction de l’hepcidine
Vaulont, S., & Labie, D. (2008) · médecine/sciences · doi:10.1051/medsci/2008242139 · Cited by 4
Self-citation
Metadata
- Authors
- Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S.
- Affiliations
- University of California San Diego (US)
- Scripps Research Institute (US)
- University of Pennsylvania (US)
- Centre National de la Recherche Scientifique (FR)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-07-02
- Volume
- 117
- Issue
- 7
- Pages
- 1926-1932
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1884690
- OpenAlex
- W2116374020
- Cited by
- 639
- References
- 36
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 19 · 2023: 25 · 2022: 26 · 2021: 34 · 2020: 32 · 2019: 18 · 2018: 36 · 2017: 28 · 2016: 31 · 2015: 30 · 2014: 35 · 2013: 39 · 2012: 43
- FWCI
- 33.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA100787)
- National Institute of Allergy and Infectious Diseases (AI060840, R01AI060840)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK073467)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- iron homeostasis, hypoxia-inducible factor, VHL, hepcidin, erythropoietin, ferroportin, iron mobilization, erythropoiesis, anemia, iron overload, hypoxia
- MeSH terms
- Ferroportin, Albumins, Animals, Base Sequence, Homeostasis, Humans, Iron, Liver, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Polycythemia, Promoter Regions, Genetic, Protein Binding, Down-Regulation, Up-Regulation, Gene Deletion, Integrases, Hepatocytes, Antimicrobial Cationic Peptides, Cation Transport Proteins, Mice, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review